| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| sch-527123 | c-x-c chemokine receptor type 1 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Inflammatory Bowel Diseases[MeSHID:D015212] Chronic Obstructive Airway Disease[MeSHID:D029424] Ulcerative Colitis[MeSHID:D003093] Malignant Neoplasms[MeSHID:D009369] |
12.73 | phase 2 | unknown |
| sch-527123 | c-x-c chemokine receptor type 2 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Inflammatory Bowel Diseases[MeSHID:D015212] Chronic Obstructive Airway Disease[MeSHID:D029424] Ulcerative Colitis[MeSHID:D003093] Malignant Neoplasms[MeSHID:D009369] |
11.57 | phase 2 | unknown |
| sch-527123 | mucosal addressin cell adhesion molecule 1 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Inflammatory Bowel Diseases[MeSHID:D015212] Chronic Obstructive Airway Disease[MeSHID:D029424] Ulcerative Colitis[MeSHID:D003093] Malignant Neoplasms[MeSHID:D009369] |
10.61 | phase 2 | unknown |
| click here to return to the previous page | ||||||||